The quantity of digitized health information has increased exponentially over the past decade, with growing data repositories across all sectors of the health system \[[@R1]\]. The rise of electronic health records has enabled the creation of large datasets containing structured, semi-structured and unstructured data, ranging from diagnostic codes and laboratory results to continuous monitoring signals, clinical notes, medical imaging and pathology. However, there are also rich clinical, molecular and environmental datasets held by government agencies, disease registries, employers, pharmaceutical companies and research organizations. Meanwhile, the proliferation of health tracking apps, wearables and home sensors have created new clinical data streams controlled by the patient, which capture granular information about lifestyle and micro-environmental exposures. Even an individual's social media footprint may be considered as a source of clinical insights. Weber *et al.* have described the spectrum of clinical data available for an individual as a "tapestry of high-value information sources" ranging from the micro (genomic/molecular data) through to the macro (behavioral/lifestyle data) \[[@R2]\].

Many have predicted that the convergence of rich clinical, molecular and environmental data streams will accelerate knowledge discovery in biomedicine and help us to move toward the high-level goal of precision medicine \[[@R3],[@R4]\]. Certainly, larger datasets combining information from numerous sources will improve the performance of diagnostic and prognostic machine learning algorithm, fuelling observational research and improving clinical decisions at the point of care. The critical challenge is how to integrate disparate clinical data streams in a flexible, query-able format while preserving patient privacy and data governance. This integration challenge may be thought of along two axes: data fusion across institutions, and data fusion across modalities.

The first challenge involves cross-institutional data sharing. Federal incentive programs launched through the Health Information Technology for Economic and Clinical Health (HITECH) Act supported the creation of health information exchanges (HIEs) as a platform for clinical data sharing; however based on a 2015 survey, only 23% of HIEs currently supported research, with a further 47% planning to support secondary use in the future \[[@R5]\]. Furthermore, a 2016 review found that the number of HIEs had declined between 2012 and 2014 and only half report being financially sustainable \[[@R6]\]. In 2015, the Office of the National Coordinator of Health IT (ONC) published an Interoperability Roadmap, which outlines a national agenda for improving health information exchange \[[@R7]\]. One key objective is achieving syntactic and semantic interoperability by adoption of common vocabularies, including SNOMED-CT and RxNorm, and common data formats, including consolidated clinical document architecture (C-CDA) and Fast Health Interoperability Resources (FHIR). The roadmap also calls for the adoption of secure transport standards and outlines best practices for matching patient identities between sites. In parallel, there have been a number of academic endeavors to build platforms for observational clinical research, including the Observational Health Data Sciences and Informatics (OHDSI) network \[[@R8]\], SHARPn project \[[@R9]\], and the Informatics for Integrating Biology and the Bedside (i2b2) initiative \[[@R10]\].

An emerging theme throughout these cross-institutional data fusion efforts, from industry to academia, is the power of ontology-driven data integration, inspired by the rise of semantic web technologies \[[@R11]--[@R13]\]. This approach has a number of distinct advantages including the ability to synthesize across many disparate data sources via high-level ontologies and the ability to reason over a knowledge base \[[@R14]\]. Ongoing technical challenges include representing data provenance, temporal relationships and data quality \[[@R15]\]; however the prevailing challenge is operational - how to shift organizational culture toward interoperability and data sharing \[[@R16]\]. Beyond this, the infrastructure for interoperability may vary, with successful examples of centralized data warehouses \[[@R17]\], decentralized blockchain-based health records systems \[[@R18]\], and patient-controlled health records \[[@R19]\].

The second major component of data fusion is cross-modality integration. Most EHRs contain a diversity of data types that have traditionally been analyzed independently, ranging from structured diagnosis codes to signal data, clinical notes and imaging. Furthermore, the interoperability advances mentioned above are making it possible to harmonize traditional EHR data with novel clinical data streams including genomic, microbiome, metabolic and patient-generated health data (PGHD). There is an expanding evidence base showing that multi-modal data integration can support precision medicine by stratifying patients based on their 'deep phenotype' \[[@R20]\]; improving the performance of clinical decision support algorithms for diagnosis and prediction \[[@R21]\]; and uncovering new phenotypes altogether \[[@R22]\]. For example, Zhao *et al.* developed a risk prediction model for cardiovascular events using EHR data, but found a significant performance boost when those data were fused with patient-level genomic information \[[@R23]\]. Meanwhile, by using unsupervised learning on a combined dataset of metabolome, microbiome, genetics and imaging data, Shomorony *et al.* were able to identify a signature of biomarkers that identified diabetic patients more accurately than traditional clinical metrics (glucose, insulin resistance, and body-mass-index) - suggesting novel pathways that may be involved in the development of diabetes \[[@R24]\].

The combination of traditional health data with PGHD or social media data has enabled knowledge discovery in the realms of both precision medicine and population health. Santillana *et al.* combined hospital visit data with Twitter, Google searches, and posts on an online health forum to predict influenza incidence \[[@R25]\]. Vilar *et al.* describe efforts to identify drug-drug interactions by combining social media posts with the biomedical literature \[[@R26]\]. On a more granular level, there is a push to integrate patient-reported outcomes (PROs) into EHRs as a way to promote patient-centric care (an example of heterogeneous data fusion potentially driving behavior change) \[[@R27]\] which has fueled interesting insights into the relationship between PROs and clinical outcomes such as mortality \[[@R28]\]. The rise of the 'Internet of Things' in healthcare - the ecosystem of connected monitoring devices that surround a patient - as well as ambient information such as geo-location are creating opportunities for even richer multi-modal datasets \[[@R29]--[@R31]\]. These data no longer reside exclusively in hospitals. Private sector initiatives such as Verily's Project Baseline and Apple's HealthKit program are enabling patients to aggregate multiple medical data sources \[[@R32],[@R33]\]. Meanwhile, the *All Of Us* initiative is a National Institutes of Health program to collect molecular, clinical and environmental data on a diverse cohort of volunteers for research purposes \[[@R34]\]. As the pathophysiology behind chronic disease is a complex interplay of clinical, molecular and behavioral factors acting over extended time periods, the datasets required to tackle the global epidemic of chronic disease will need to be similarly layered and sophisticated. There is both a clinical opportunity and an economic one, with increasing evidence to suggest that data integration can reduce overall healthcare costs \[[@R35]\].

Cross-modality data integration is associated with a number of challenges, of which we highlight three below. First, there is the issue of how to harmonize data from distant parts of a knowledge graph reflecting radically different levels of abstraction e.g. diagnosis codes (high-level) with proteomic data (low-level). This creates challenges for data storage and makes it difficult to generate feature vectors to train classifiers. Several recent studies have shown that deep learning can be used to create efficient abstract representations of structured and unstructured EHR data, for example the *DeepPatient* representation using stacked denoising autoencoders \[[@R36]\]. A similar approach might be considered for a broader range of input data. A second caveat is around data stewardship, particularly with respect to privacy and security \[[@R37]\]. Fusion of data streams may accelerate scientific discovery and clinical care, but this comes with an increased risk of patient re-identification. Further work is needed around de-identification, consent processes and access control when data are contributed to shared repositories. The increasing volume of digital health information available to clinicians also raises questions around liability and duty of care i.e. the extent to which clinicians are responsible for the full expanse of information in an aggregated health repository. A third challenge is around equity and inclusion. A 2018 report by Ferryman *et al.* on 'Fairness in precision medicine' highlights the potential for bias in large-scale biomedical training data, stemming from historical discrimination in the health system and recruitment biases at academic medical centers \[[@R38]\]. Data-fusion efforts must be cognizant of the distribution of important demographic variables, such as gender, ethnicity and socioeconomic status in their input data.

The fusion of heterogeneous datasets from different institutions and across different modalities presents a powerful opportunity to drive knowledge discovery in biomedicine. There are technical and operational challenges to enable data sharing across borders of institutional ownership, which we are beginning to overcome with interoperability standards and data sharing platforms. Arguably the more nuanced problem today is how to grapple with extremely diverse data types that encompass the micro and macro scales of a patient's data signature, including how to create flexible data storage and machine learning architectures, and how to design stewardship processes to govern these data appropriately. Holzinger *et al.* claimed in 2014 that "biomedical research is drowning in data, yet starving for knowledge". Today we have more health data than ever before, but the challenge remains how to harmonize, structure and learn from multi-modal datasets \[[@R39]\].
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